trial
as of 2026-07-01The ATP Project (Antipsychotic-TEP-Psychosis)
NCTId NCT06651112
at a glance
Phase — · Not Yet Recruiting
Enrollment 18 (estimated)
Sponsored by Université de Sherbrooke
Primary completion 2026-11-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Not Yet Recruiting
Enrollment
18 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2024-11-01
Primary completion
2026-11-01
Eligibility
ALL · 18 Years · 35 Years
Interventions & indications
Sponsors
Université de SherbrookeLead Sponsor
Baszucki Brain Research FundCollaborator
Investigators
3
Stephen J Heishman, Ph.D.Principal Investigator
Kevin Zemmour, MDPrincipal Investigator
Maggie Hahn, MDPrincipal Investigator
Sites
1 total
Sherbrooke, Canada
Facts & assertions
4 sourced
Enrollment
18
Phase
NA
Primary Completion Date
2026-11-01
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
company
indication
investigator